Shandong Sito Bio-technology (300583.SZ): Methylprednisolone obtains European CEP certificate for chemical raw materials.

Shandong Sito Bio-technology (300583.SZ) announced that its controlling subsidiary, Shandong Sito Pharmaceutical Co., Ltd. (referred to as "Sito Pharmaceutical"), recently received a Certificate of Suitability to the European Pharmacopoeia (CEP) for the active pharmaceutical ingredient methylprednisolone issued by the European Directorate for the Quality of Medicines. The announcement states that methylprednisolone is a medium-effect, non-halogenated corticosteroid drug used in the emergency treatment of critical diseases. It can also be used for endocrine disorders, rheumatic diseases, collagen diseases, skin diseases, allergic reactions, ophthalmic diseases, gastrointestinal diseases, blood diseases, leukemia, shock, cerebral edema, multiple neuritis, myelitis, and to prevent vomiting caused by cancer chemotherapy, among other uses.